Multicentre acute stroke trial - Italy [1]

Lancet

Volumn 347, Issue 8998, 1996, Pages 391-393

  Muir, K W ^a   Barer, D ^a   Carolei, A ^a   Marini, C ^a   Motolese, M ^a   Rothwell, P ^a   Candelise, L ^a   Aritzu, E ^a   Ciccone, A ^a   Ricci, S ^a   Wardlow, J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE;

BLOOD CLOT LYSIS; DISABILITY; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; LETTER; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TIME; ACUTE DISEASE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; MULTICENTER STUDY; NOTE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ACUTE DISEASE; ASPIRIN; BRAIN ISCHEMIA; HUMANS; ITALY; RESEARCH DESIGN; RISK FACTORS; STREPTOKINASE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0039610264     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90568-1     Document Type: Letter

References (24)

1. Multicentre Acute Stroke Trial—Italy (MAST-I) Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke Lancet 346 1995 1509 1514
2. P. Sandercock Thrombolytic therapy for acute ischaemic stroke: promising, perilous or unproven? Lancet 346 1995 1504 1505
3. G. Tognoni Mc Roncaglioni Dissent: an alternative interpretation of MAST-I Lancet 346 1995 1515
4. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
5. Ad Morris Dg Grosset Ib Squire Kr Lees I. Bone Jl Reid The experiences of an acute stroke unit—implications for multicentre acute stroke trials J Neurol Neurosurg Psychiatry 56 1993 352 355
6. Multicentre Acute Stroke Trial—Italy (MAST-I) Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke Lancet 346 1995 1509 1514
7. R. Horton MAST-I: Agreeing to disagree Lancet 346 1995 1504
8. P. Sandercock Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven? Lancet 346 1995 1504 1505
9. W. Hacke M. Kaste C. Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS) JAMA 274 1995 1017 1025
10. D. Barer, J. Ellul, From meta-analysis to epi-analysis: the European Stroke Project In: Gn Fracchia, Kh Haavisto (Eds), European Medicines Research, European Conference Publications, Brussels ((in press)).
11. Multicentre Acute Stroke-Italy (MAST-I) Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke Lancet 346 1995 1509 1514
12. G. Tognoni Mc Roncaglioni Dissent: an alternative interpretation of MAST-I Lancet 346 1995 1515
13. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet i 1986 397 401
14. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
15. Multicentre Acute Stroke Trial—Italy (MAST-I) Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke Lancet 346 1995 1509 1514
16. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischaemic stroke N Engl J Med 333 1995 1581 1587
17. P. Sandercock Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven? Lancet 346 1995 1504 1505
18. Na Solomon Ha Glick Cj Russo J. Lee Ka Schulman Patient preferences for stroke outcomes Stroke 25 1994 1721 1725
19. Pm Rothwell Can overall results of clinical trials be applied to all patients Lancet 346 1995 1616 1619
20. National Institutes of Health Thrombolytic therapy in thrombosis Stroke 12 1981 17 21
21. M. Hommel Jp Boissel C. Cornu Termination of trial of streptokinase in severe acute ischaemic stroke Lancet 345 1995 57
22. Ga Donnan Sm Davis Br Chambers Trials of streptokinase in severe acute ischaemic stroke Lancet 345 1995 578 579
23. W. Hacke M. Kaste C. Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for treatment in acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS) JAMA 274 1995 1017 1025
24. The NINDS rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587